Clopidogrel as prophylactic treatment for migraine.

Trial Profile

Clopidogrel as prophylactic treatment for migraine.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Nov 2014

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Migraine with aura; Migraine without aura
  • Focus Therapeutic Use
  • Acronyms ClopMig
  • Most Recent Events

    • 05 Apr 2013 Accrual to date is 100% according to United Kingdom Clinical Research Network record.
    • 28 Mar 2013 Accrual to date is 85% according to United Kingdom Clinical Research Network record.
    • 22 Oct 2011 United Kingdom Clinical Research Network reports accrual to date changed from 24% to 69%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top